Free Trial
→ JD Vance Predicts: Wall Street vs. Trump & Your Money (From Priority Gold) (Ad) Free ATHA Stock Alerts

Athira Pharma (ATHA) Insider Trading & Ownership

Athira Pharma logo
$0.64 0.00 (-0.36%)
(As of 11:45 AM ET)
Compare

Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.80%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$563,684.04
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$29,592.93
Get ATHA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATHA Insider Buying and Selling by Quarter

Ad Darwin
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!

Athira Pharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/5/2024Andrew GengosCFOSell1,272$0.57$725.04  
9/5/2024Mark James LittonCEOSell5,032$0.57$2,868.24  
9/5/2024Rachel LeningtonCOOSell2,525$0.57$1,439.25  
6/24/2024Kelly A RomanoDirectorBuy27,400$2.42$66,308.00  
6/21/2024Kelly A RomanoDirectorBuy15,000$2.26$33,900.00  
1/5/2024Andrew GengosInsiderSell1,208$2.91$3,515.28  
1/5/2024Mark James LittonCEOSell4,820$2.91$14,026.20  
1/5/2024Mark WorthingtonGeneral CounselSell2,412$2.91$7,018.92  
12/29/2023Perceptive Advisors LlcDirectorBuy163,954$2.38$390,210.52  
12/27/2023Perceptive Advisors LlcDirectorBuy32,134$2.28$73,265.52  
(Data available from 1/1/2013 forward)

ATHA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Athira Pharma includes Andrew Gengos, Glenna Mileson, Hans Moebius, James A Johnson, Kelly A Romano, Mark James Litton, Mark Worthington, Perceptive Advisors Llc, and Rachel Lenington. Learn more on insiders at ATHA.

19.80% of Athira Pharma stock is owned by insiders. Learn more on ATHA's insider holdings.

The following insiders have purchased ATHA shares in the last 24 months: Andrew Gengos ($242,883.84), Glenna Mileson ($142,500.00), James A Johnson ($12,000.00), Kelly A Romano ($198,908.00), and Perceptive Advisors Llc ($463,476.04).

Insiders have purchased a total of 403,500 ATHA shares in the last 24 months for a total of $1,059,767.88 bought.

The following insiders have sold ATHA shares in the last 24 months: Andrew Gengos ($4,240.32), Mark James Litton ($16,894.44), Mark Worthington ($7,018.92), and Rachel Lenington ($1,439.25).

Insiders have sold a total of 17,269 Athira Pharma shares in the last 24 months for a total of $29,592.93 sold.

Athira Pharma Key Executives

  • Dr. Mark J. Litton M.B.A. (Age 56)
    Ph.D., President, CEO & Director
    Compensation: $882.7k
  • Mr. Andrew W. Gengos (Age 60)
    CFO & Chief Business Officer
    Compensation: $396.16k
    1 recent trades
  • Ms. Rachel P. Lenington M.B.A. (Age 51)
    Chief Development Officer & COO
    Compensation: $578k
  • Dr. Kevin Church Ph.D. (Age 39)
    Chief Scientific Officer
    Compensation: $123.67k
  • Ms. Julie Rathbun
    Head of Investor Relations
  • Mr. Mark F. Worthington J.D. (Age 58)
    General Counsel & Corporate Secretary
    Compensation: $503.83k
  • Ms. Samantha Willing
    Chief People Officer
  • Dr. Javier San Martin M.D. (Age 59)
    Chief Medical Officer

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:ATHA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Crypto’s next big bull run?
Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...
Weiss Ratings | Sponsored
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...
Colonial Metals | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored